Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer
Clinical trial NCT00509366 · TERMINATED
Trial details
- NCT number
- NCT00509366
- Sponsor
- Duke University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2011-12-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.